Treatment for Basal Cell Carcinomas (BCCs) in Gorlin Syndrome Patients
1 clinical trials · Condition
◉ Watch Treatment for Basal Cell Carcinomas (BCCs) in Gorlin Syndrome Patients
| Record | Firm | Date |
|---|---|---|
| A Trial to Evaluate the Safety, Local Tolerability, Pharmacokinetics and Pharmacodynamics of LDE225 on Skin Basal Cell Carcinomas in Gorlin Syndrome Patients (NCT00961896) | Novartis Pharmaceuticals | 2009-07-01 |
Track Treatment for Basal Cell Carcinomas (BCCs) in Gorlin Syndrome Patients automatically
Every clearance here is in the API, with alerts when new ones post.